Adler M, Delhaye M, Deprez C, Hardy N, Gelin M, De Pauw L, Vereerstraeten P, Cremer M, Toussaint C
Nephrol Dial Transplant. 1987;2(3):183-8.
Severe hepatic vascular disease developed in two patients 4 and 8 years after kidney transplantation, while receiving combined immunosuppressive therapy with prednisone and azathioprine. Portal hypertension and marked liver failure were observed in both cases. The diagnosis was established by histological examination of liver biopsies showing typical veno-occlusive disease of the liver associated with peliosis in both cases. Azathioprine was discontinued. Two years later one patient was asymptomatic and liver function tests were normal. The second patient died 3 years later from liver failure. Early recognition of hepatic vascular disease arising in kidney transplant recipients would be of utmost importance, as substitution of another immunosuppressive agent for azathioprine could halt the process leading to portal hypertension.
两名患者在肾移植术后4年和8年出现严重肝血管疾病,当时正在接受泼尼松和硫唑嘌呤联合免疫抑制治疗。两例均观察到门静脉高压和明显的肝功能衰竭。通过肝活检组织学检查确诊,两例均显示典型的肝静脉闭塞性疾病并伴有肝紫癜。停用硫唑嘌呤。两年后,一名患者无症状,肝功能检查正常。第二名患者3年后死于肝功能衰竭。尽早识别肾移植受者出现的肝血管疾病至关重要,因为用另一种免疫抑制剂替代硫唑嘌呤可以阻止导致门静脉高压的进程。